Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Haduvio’s unique centrally and peripherally active mechanism of action (MOA) has the potential to rebalance the kappa ...
Use this information to figure out if this company is an ideal customer for you.
1 (203) 304-2499
195 Church Street
New Haven, 06510
51 - 200 Employees
$1M - $5M
linkedin.com/company/trevi-therapeutics-inc-
Trevi Therapeutics’s CEO is Jennifer Good
Trevi Therapeutics’s CFO is Lisa Delfini
Trevi Therapeutics’s HQ is located at 195 Church Street, New Haven
Trevi Therapeutics’s phone number is 1 (203) 304-2499
Trevi Therapeutics’s official website is trevitherapeutics.com
Trevi Therapeutics’s revenue is $1M - $5M
Trevi Therapeutics has 51 - 200 employees
Trevi Therapeutics is in the industry of: Pharmaceuticals
